ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.

February 6, 2004

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013